加巴喷丁治疗自闭症谱系障碍合并智力障碍患者的挑战行为:病例报告

Stefano Marini, Lucia D'Agostino, Carla Ciamarra, Domenico De Berardis, Alessandro Gentile
{"title":"加巴喷丁治疗自闭症谱系障碍合并智力障碍患者的挑战行为:病例报告","authors":"Stefano Marini, Lucia D'Agostino, Carla Ciamarra, Domenico De Berardis, Alessandro Gentile","doi":"10.1108/amhid-06-2023-0021","DOIUrl":null,"url":null,"abstract":"Purpose\nThe purpose of this case report is to report the clinical experience of the use of gabapentin in the management of problem behaviors in a person with autism spectrum disorder and comorbid intellectual disability. Autism spectrum disorder is a neurodevelopmental disorder with a high prevalence of intellectual disability. Challenging behaviors in autism spectrum disorder are very common. In recent years, the hypothesis that the symptoms of autism derive from a deficiency of the inhibitory neurotransmission of gamma-aminobutyric acid is gaining considerable weight.\n\nDesign/methodology/approach\nExploring behavioral symptoms improvement in an adult man with ASD and severe intellectual disability taking gabapentin.\n\nFindings\nThe rating scales used show improvement in challenging behaviors and aggressions. No side effects were observed.\n\nOriginality/value\nCurrently, there are no authorized drugs for the treatment of the symptomatic features of autism spectrum disorder, but drugs are used for comorbid psychopathological aspects. The authors want to speculate on a hypothetical function of gabapentin in remodeling the expression of alpha-2-delta subunits in people with autism and the processing of neural information.\n","PeriodicalId":44693,"journal":{"name":"Advances in Mental Health and Intellectual Disabilities","volume":null,"pages":null},"PeriodicalIF":1.2000,"publicationDate":"2024-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Gabapentin treatment for challenging behaviors in autism spectrum disorder and coexisting intellectual disability: a case report\",\"authors\":\"Stefano Marini, Lucia D'Agostino, Carla Ciamarra, Domenico De Berardis, Alessandro Gentile\",\"doi\":\"10.1108/amhid-06-2023-0021\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Purpose\\nThe purpose of this case report is to report the clinical experience of the use of gabapentin in the management of problem behaviors in a person with autism spectrum disorder and comorbid intellectual disability. Autism spectrum disorder is a neurodevelopmental disorder with a high prevalence of intellectual disability. Challenging behaviors in autism spectrum disorder are very common. In recent years, the hypothesis that the symptoms of autism derive from a deficiency of the inhibitory neurotransmission of gamma-aminobutyric acid is gaining considerable weight.\\n\\nDesign/methodology/approach\\nExploring behavioral symptoms improvement in an adult man with ASD and severe intellectual disability taking gabapentin.\\n\\nFindings\\nThe rating scales used show improvement in challenging behaviors and aggressions. No side effects were observed.\\n\\nOriginality/value\\nCurrently, there are no authorized drugs for the treatment of the symptomatic features of autism spectrum disorder, but drugs are used for comorbid psychopathological aspects. The authors want to speculate on a hypothetical function of gabapentin in remodeling the expression of alpha-2-delta subunits in people with autism and the processing of neural information.\\n\",\"PeriodicalId\":44693,\"journal\":{\"name\":\"Advances in Mental Health and Intellectual Disabilities\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.2000,\"publicationDate\":\"2024-06-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Advances in Mental Health and Intellectual Disabilities\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1108/amhid-06-2023-0021\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"PSYCHIATRY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in Mental Health and Intellectual Disabilities","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1108/amhid-06-2023-0021","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0

摘要

目的 本病例报告旨在介绍使用加巴喷丁治疗自闭症谱系障碍和合并智力障碍患者问题行为的临床经验。自闭症谱系障碍是一种神经发育障碍,智障的发病率很高。自闭症谱系障碍患者的挑战行为非常普遍。近年来,自闭症症状源于γ-氨基丁酸抑制性神经递质缺乏的假说越来越受到重视。设计/方法学/方法探讨一名患有自闭症谱系障碍和严重智障的成年男子服用加巴喷丁后行为症状的改善。原创性/价值目前,尚无授权药物用于治疗自闭症谱系障碍的症状特征,但有药物用于治疗合并精神病理学方面的症状。作者希望推测加巴喷丁在重塑自闭症患者体内α-2-δ亚单位的表达和神经信息处理方面的假设功能。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Gabapentin treatment for challenging behaviors in autism spectrum disorder and coexisting intellectual disability: a case report
Purpose The purpose of this case report is to report the clinical experience of the use of gabapentin in the management of problem behaviors in a person with autism spectrum disorder and comorbid intellectual disability. Autism spectrum disorder is a neurodevelopmental disorder with a high prevalence of intellectual disability. Challenging behaviors in autism spectrum disorder are very common. In recent years, the hypothesis that the symptoms of autism derive from a deficiency of the inhibitory neurotransmission of gamma-aminobutyric acid is gaining considerable weight. Design/methodology/approach Exploring behavioral symptoms improvement in an adult man with ASD and severe intellectual disability taking gabapentin. Findings The rating scales used show improvement in challenging behaviors and aggressions. No side effects were observed. Originality/value Currently, there are no authorized drugs for the treatment of the symptomatic features of autism spectrum disorder, but drugs are used for comorbid psychopathological aspects. The authors want to speculate on a hypothetical function of gabapentin in remodeling the expression of alpha-2-delta subunits in people with autism and the processing of neural information.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
1.60
自引率
18.20%
发文量
22
期刊最新文献
Gabapentin treatment for challenging behaviors in autism spectrum disorder and coexisting intellectual disability: a case report The effectiveness of family-based treatment and pharmacotherapy in an adolescent with anorexia nervosa and intellectual disability: a case report Health literacy in parents of children with Down syndrome STOMP during COVID-19: use of psychotropic medication in intellectual disabilities community services – pilot QI project Co-design and pilot of a virtual reality intervention to improve mental and physical healthcare accessibility for people with intellectual disability
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1